Working… Menu

cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project (KitMel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01543113
Recruitment Status : Completed
First Posted : March 2, 2012
Last Update Posted : February 24, 2014
QIAGEN Gaithersburg, Inc
Information provided by (Responsible Party):
Rennes University Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2012
Actual Study Completion Date : February 2014